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Abstract 
In the human breast carcinoma cell line (MCF-7), exogenous TGF-fl 1 induces a dose-dependent i hibition of cell proliferation. In a 
MCF-7 cell subline [MCF-7(-)], which has an undetectable l vel of type II TGF-fl receptor, exogenous TGF-fl 1 does not inhibit cell 
proliferation but is still able to induce its own message. In both cell lines, TGF-/31 stimulates expression of c-jun, whereas a rapid, 
transient and marked increase in c-fos mRNA is only observed in the MCF-7 cells sensitive to the growth inhibitory effect of TGF-fl 1. 
Depletion of protein kinase C abolishes the c-fos but not the c-jun response to TGF-/31. Our results suggest that growth inhibition and 
autoinduction by TGF-fl 1 are mediated by different signalling pathways. In addition, aPKC-dependent increase in c-fos expression seems 
to be associated with the growth inhibitory effect of TGF-/31. 
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1. Introduction 
Transforming rowth factor-/31 (TGF-/31) is a 25kDa 
multifunctional polypeptide which, depending on the cell 
type and cell environment, regulates proliferation, differen- 
tiation (reviewed in Ref. [1]) and death [2] in both normal 
and tumoral ceils. TGF-/31 inhibits epithelial cell prolifera- 
tion by arresting the progression of the cell cycle at the 
G1/S  transition [3]. Several genes involved in the control 
of G1 progression and the transition into S-phase have 
been shown to be affected by TGF-fl 1. Indeed TGF-/31 
prevents phosphorylation of the product of the retinoblas- 
toma gene (Rb), retaining Rb in a hypophosphorylated 
state that may suppress progression into the S-phase [4]. 
Rb is phosphorylated by cdk2 and cdk4 (cyclin- 
dependent-kinases), and the activities of these enzymes are 
inhibited by TGF-fl 1 [5,6]. In addition to its potent growth 
inhibitory activity, TGF-fl 1 regulates its own expression 
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[7] and is an inducer of extracellular matrix gene expres- 
sion [8]. TGF-fl 1 mediates its effects through type I and 
type II TGF-fl high-affinity receptors, which have been 
shown to be serine-threonine kinases [9,10]. It has also 
been shown that the biological effects of TGF-fl 1 require 
coordination of type I and type II TGFfl receptors [11]. 
However, inactivation of type II TGF-fl receptors abol- 
ishes the antiproliferative effect of TGF-/31 without affect- 
ing its effects on the extracellular matrix [12]. The diverse 
biological actions of TGF-fl 1 may also be related to its 
capacity to initiate different genomic programs in target 
cells. These effects are mediated via the induction of 
immediate arly genes. TGF-fl 1 activates c-jun, jun B and 
c-fos [13-16] and represses c-myc proto-oncogenes [17]. 
Repression of c-myc has been linked to the growth in- 
hibitory activity of TGF-/31 [3], whereas increase in the 
expression of jun B is associated with the responses of the 
extracellular matrix to TGF-fl l  [13,18]. The intervention 
of c-fos expression i  the biological effects of TGF-fl 1 has 
yet to be elucidated in detail. 
Proliferation of human breast adenocarcinoma MCF-7 
cells is inhibited by exogenous TGF-fl 1. However, a loss 
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of sensitivity to the antiproliferative effect of TGF-/31 is 
observed with time in culture, which is correlated with an 
undetectable l vel of type II TGF-fl receptor [9]. We have 
previously shown that in a later passage of MCF-7 cells, 
which are insensitive to the growth inhibitory effect of 
TGF-fl l  [MCF-7(-)],  this growth factor increases the 
antiproliferative effect of retinoic acid [19], suggesting that 
these MCF-7( - )  cells are not totally insensitive to TGF- 
/31. 
In the present study, we examined TGF-/3 1 autoinduc- 
tion and early gene responses in cells that are either 
sensitive (MCF-7) or insensitive [MCF-7( - )] to the growth 
inhibitory effect of TGF-131. We found that autoinduction 
of TGF-/31 and increase in c-jun gene expression are 
independent of its antiproliferative ffect, whereas the 
induction of c-fos expression is only observed in the 
MCF-7 cells that are sensitive to the growth-inhibitory 
effect of TGF-fl 1. In addiition, our results indicate that the 
protein kinase C (PKC) signal transduction pathway is 
involved in the TGF-/3 1-induced expression of c-fos but 
not c-jun in the MCF-7 cell line. 
2. Materials and methods 
2.1. Chemicals 
Porcine TGF-/31 was purchased from R and D Systems 
(Minneapolis, MN, USA). 12-O-Tetra-decanoyl-phorbol 
13-acetate (TPA) and bis(sulfosuccinimidyl)suberate (BS 3) 
were respectively obtained from Sigma and Pierce. [a- 
32p]dCTP (3000 Ci/mmol) and [125I]TGF-/31 (3000 
Ci/mmol) were obtained from Dupont De Nemours 
(NEN). 
2.4. Preparation of cellular RNA 
Total cellular RNA was extracted using the guani- 
dinium thiocyanate procedure as described by Chomczyn- 
ski and Sacchi [20]. 
2.5. Northern blot analysis 
Samples of 15 /xg of RNA were electrophoresed in a 
1.2% agarose gel containing 2.2 M formaldehyde and then 
transferred to a nylon membrane (Hybond N, Amersham). 
The cDNA probes used were the PAI-1 0.6 kb SaclI-NcoI 
fragment in pUC9, the c-jun 1.3 kb HindlII-EcoRI frag- 
ment in pBSM13, the jun B 1.46 kb EcoRI-EcoRI frag- 
ment in pGEM, the jun D 1.43 kb EcoRI-EcoRI fragment 
in pBSM13, the c-fos 1.3 kb HindlII-EcoRI fragment in 
pSP64. Prehybridization was carried out at 42 ° C for 2-4  h 
in a buffer containing 50% formamide, 6 X SSPE (1 X 
SSPE is 0.01 M sodium phosphate buffer [pH 7.4] contain- 
ing 0.15 M NaC1 and 1 mM EDTA), 0.5% SDS, 5 × 
Denhart's olution (1 × Denhart's olution is 0.02% bovine 
serum albumin, 0.02% Ficoll 400 and 0.02% 
polyvinylpyrrolidone) and 100 /xg/ml denatured salmon 
sperm DNA. Hybridization was performed under the same 
conditions as prehybridization for 16-20 h, using 32p 
cDNA probes labeled by the random priming method 
(Megaprime DNA labeling system, Amersham). The mem- 
branes were washed at 42°C twice in 2 X SSPE-0.1% 
SDS and twice in 0.1 X SSPE-0.1% SDS. After washing, 
the filters were exposed to Amersham Hyperfilm MP at 
-80°C using intensifying screens. To ensure that equal 
2.2. Cell cultures 
MCF-7 cells were obtained from American Type Cul- 
ture Collection. MCF-7( - )  correspond to the same cell 
line but has been maintained for a long period of time in 
culture. The MCF-7 and MCF-7(-) cells used in this study 
were respectively in their 150-170th passage and in their 
300-320th passage. Cells were grown in humidified 5% 
CO2/95% air at 37°C in RPMI 1640 medium supple- 
mented with sodium bicarbonate (2 g/ l) ,  2 mM glutamine, 
1 /zM insulin and 4% fetal calf serum. CCL-64 cells were 
grown in MEM medium supplemented with sodium bicar- 
bonate (2 g/l),  2 mM glutamine and 5% fetal calf serum. 
2.3. Cell growth experiments 
Cells were plated in 35-mm Petri dishes at a density of 
5000 cel ls/cm 2. On the following day, the media were 
changed and various concentrations of TGF-/31 (from 1 to 
80 pM) were added. The media were changed on day 3 
and cell numbers were determined on day 4. 
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Fig. 1. Effect of increasing concentrations f TGF-/31 on MCF-7 [O] and 
MCF-7(-) [0] cell proliferation. Cells were plated at a density of 5000 
cells/cm 2 in 35-mm Petri dishes. Various concentrations of TGF-/31 
were added 24 h later. Cell numbers were determined 4 days after the 
addition of TGF-/31. The results represent the mean + S.D. of 3 indepen- 
dent experiments. 
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Fig. 2. Effect of TGF-fl 1 on TGF-fl 1 and PAI-1 mRNA levels in MCF-7 and MCF-7( - )  cells. Cells were treated with 20 pM TGF-fl 1 and total RNA 
were isolated at the indicated times. (A) The TGF-fll mRNA level was determined by RNase protection assay. (B) The PAl-1 mRNA level was 
determined by Northern blot analysis. Hybridization to the constant 36B4 probe indicated equal loading of the lanes. 
amounts of RNA were present in the different lanes, the 
filters were probed with a 0.6 kb 36B4 cDNA fragment 
[21]. Autoradiograms were analyzed by laser densitometric 
scanning (Biocom Analyser). 
2.6. RNase protection assay 
The sense and antisense TGF-fl 1 RNA probes were 
constructed as previously described [22]. Hybridizations 
were performed according to Winter et al. [23]. 30/xg total 
cellular RNA were combined with the labeled RNA probe 
(5 X 105 cpm) in 30 /~1 hybridization buffer (80% for- 
mamide, 400 nM NaC1, 1 mM EDTA, 40 mM Pipes pH 
6.7), heated to 85°C for 5 min and incubated at 55°C for 
16 h. RNA were digested by addition of 300 /xl of buffer 
(300 mM NaCI, 5 mM EDTA, 10 mM Tris-HC1 pH 7.5) 
containing RNase A (40/xg/ml) and RNase T1 (2 /xg/rnl) 
and incubated for 2 h at 37 ° C. The digestions were 
terminated by addition of 5 /xi proteinase K (10 mg/ml) 
and further incubation for 20 min at the same temperature. 
Carder tRNA (10 /zg) was added, followed by extraction 
and isopropanol precipitation. RNA pellets were washed 
with 70% cold ethanol, dried, redissolved in 10 /zl of 
sample buffer (97% formamide, 0.1% SDS, 10 mM Tris- 
HCI pH 7, bromophenol blue 1 mg/ml, xylene cyanol 1 
mg/ml), heated at 85°C for 5 min and loaded onto a 5% 
acrylamide/7 M urea gel. Gels were dried and exposed to 
Amersham Hyperfilm MP. 
2.7. TGF-fl receptor affinity labeling 
Subconfluent cells were affinity-labeled using 80 pM 
[125I]TGF-fl I in presence or absence of 4 nM unlabeled 
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Fig. 3. Chemical cross-linking of [125I]-labeled TGF-/31 to CCL-64, MCF-7 and MCF-7( - ) cells in absence (lane 1) or presence (lane 2) of 50-fold excess 
of unlabeled TGF-fl 1. The position of the three labeled TGF-/3 receptor types and the position of molecular size markers are indicated in the 
autoradiograms. 
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TGF- f l  1. TGF- f l  1 b ind ing sites on intact monolayers  were 
cross- l inked to [125I]TGF-.fl 1 us ing BS 3 according to Ref. 
[24]. Detergent  extracts f rom aff inity labeled cells were 
separated on 7% polyacrylamide g ls under educing con- 
ditions. For autoradiography, the dried gels were exposed 
to Amersham Hyperfilm MP at -80°C for 7 days. 
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Fig. 4. Expression of c-fos, c-jun, jun B and jun D in response to TGF-fl 1 in MCF-7 and MCF-7( - ) cells. (A) Northern blot analysis of c-fos and c-jun 
mRNA expression i MCF-7 and MCF-7(- ) cells after treatment by TGF-fl 1 (20 pM). Total RNA were isolated at the indicated times and hybridized to 
the 32 P-labeled c-fos and c-jun 10robes. Hybridization to the constant 36B4 probe indicated equal oading of the lanes. (B) Quantification of the mRNA 
inductions, c-fos, c-jun, jun B and jun D mRNA were normalized to 36B4 mRNA by densitometric s anning. Results were expressed as -fold induction of 
the basal mRNA levels measured in untreated cells. O, MCF-7 cells; O, MCF-7(- ) cells. 
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3. Results 
3.1. Effects of  TGF-f l l  on MCF-7 and MCF-7( -  ) cells 
As shown in Fig. 1, TGF-/31 induced a dose-dependent 
inhibition of MCF-7 cell proliferation (IC50 = 5 pM), 
whereas it failed to affect proliferation of MCF-7( - ) cells 
for concentrations up to 80 pM. We also checked for the 
absence of other effects of TGF-/31 in the MCF-7( - )  
cells. It has been previously shown that TGF-fl 1 is able to 
induce its own message [7,15]. Using an RNase protection 
assay, we measured the effect of exogenous TGF-fl 1 on 
TGF-/31 mRNA levels in MCF-7 and MCF-7( - ) cells, As 
shown in Fig. 2A, TGF-/31 treatment (20 pM) resulted in a 
time-dependent increase in TGF-/31 mRNA in both cell 
lines; maximal effect was observed 24 h after addition of 
TGF-fl 1. TGF-fl 1 has also been shown to stimulate the 
expression of plasminogen activator inhibitor-I (PAl-l) in 
various cell lines [25]. Northern blot analysis indicated an 
increase in PAI-1 mRNA after TGF-/31 addition both in 
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Fig. 5. Effect of PKC depletion on TGF-/31 induced c-fos and c-jun expression i MCF-7 cells. MCF-7 cells were pretreated in presence or absence of 100 
ng/ml  TPA for 24 h and subsequently stimulated with 100 ng /ml  TPA or 20 pM TGF-fl 1. Total RNA extracted at different imes after the addition of 
TPA or TGF-/31 were subjected to Northern blot analysis with the radiolabeled probes for c-fos and c-jun. (A) Northern blot analysis of c-fos and c-jun 
mRNA expression. (B) Quantification of the mRNA inductions, c-fos and c-jun mRNA levels were normalized to 36B4 mRNA expression by 
densitometric s anning. Results were expressed as -fold induction of the basal mRNA levels measured in untreated cells. 0 ,  no pretreatment TPA; O, 
pretreatment TPA; unbroken line, TGF-fl 1 treatment; dashed line, TPA treatment. 
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Table 1 
Summary of different effects of TGF-/31 in MCF-7 and MCF-7( - ) cells 
293 
Receptortype 
MCF-7 MCF-7( - ) 
I I 
II I1 (undetectable) 
III III 
Proliferation inhibition yes no 
Expression of c-fos mRNA induction (10-fold) no induction 
Expression of c-jun mRNA induction (3-fold) induction (1,5-fold) 
Autoinduction yes yes 
MCF-7 and MCF-7( - )  cells which is maximal 3 h after 
TGF-fl 1 addition (Fig. 2B). At this time, the amount of 
PAI-1 mRNA was increased 3.5-fold and 2-fold respec- 
tively in MCF-7 and MCF-7( - )  cells. Thus MCF-7( - )  
cells are not defective in responding to TGF-fl 1 regarding 
autoinduction and induction of a matrix-associated protein. 
3.2. Expression of TGF-fl receptors in MCF-7 and MCF- 
7( - ) cells 
Results of cross-linking experiments are reported in Fig. 
3. CCL-64 cells, used as control cells, expressed three 
detectable TGF-/3 binding proteins type I (53 kDa), type II 
(70 kDa) and type III (300 kDa) as previously described 
[26]. The expression of TGF-fl receptors was lower in 
MCF-7 cell sublines compared to CCL-64 cells. In MCF-7 
cells, a specific labeling of [125I]TGF-f11 was detectable 
above 200 kDa (type III TGF-/3 receptor) and between 70 
and 90 kDa, suggesting an overlap of type I and type II 
TGF-fl receptors. In MCF-7(-  ) cells, no specific labeling 
could be observed at a position corresponding to type II 
TGF-fl receptor, whereas type I receptor was detected as a 
single specific labeled protein (70 kDa). 
3.3. Effect of TGF-fll on immediate arly genes mRNA in 
MCF-7 and MCF-7( - ) cells 
We examined the effect of TGF-fl 1 on immediate arly 
genes mRNA levels in both MCF-7 and MCF-7(- ) cells. 
As shown in Fig. 4A, TGF-/31 treatment (20 pM) rapidly 
enhanced c-jun expression i  both cell lines. However, the 
magnitude of the induction was higher in MCF-7 cells 
compared to MCF-7( - )  cells: when normalized to the 
36B4 mRNA signal the amount of c-jun mRNA was 
increased 3-fold and 1.5-fold respectively in MCF-7 and 
MCF-7(-  ) cells (Fig. 4B). TGF-/31 induced only a slight 
rise (1.5 to 2-fold) in jun D and jun B mRNA levels in 
both cell lines (Fig. 4B). TGF-B 1 elicited a rapid and 
transient induction of c-fos mRNA (10-fold) in the MCF-7 
cells: c-fos mRNA reached a peak 30 min after addition of 
TGF-/~ 1 and then returned to basal levels at 3 h (Fig. 
4A,B). Under similar conditions, TGF-/31 failed to induce 
c-fos expression i  the MCF-7(-  ) cell line (Fig. 4A,B). 
These results indicate that induction of the jun gene 
family occurred in MCF-7 cells irrespective of whether 
they were sensitive or resistant o the antiproliferative 
effect of TGF-fl 1, whereas induction of c-fos was only 
observed in the MCF-7 cells whose growth was inhibited 
by TGF-/31. 
3.4. Effect of PKC desensitization on the TGF-fll-induced 
expression of c-fos and c-jun mRNA in MCF-7 cells 
Activation of PKC has been shown to induce immediate 
early gene expression i  various cell types [27]. We there- 
fore examined whether TGF-/31 induced expression of 
c-fos and c-jun was dependent on PKC activation. It has 
been shown that activation of PKC by TPA inhibits cell 
proliferation and induces cell differentiation i  MCF-7 
cells [28,29]. When these cells were subjected to chronic 
treatment with TPA (100 ng/ml, 24 h), a depletion of 
PKC activity was observed [30]. We have checked that 
TPA induced an increase in levels of c-fos (20-fold) and 
c-jun mRNA (4.5-fold) in MCF-7 cells (Fig. 5A,B). When 
TPA was added to chronically TPA-treated MCF-7 cells, 
there was no increase in c-fos and c-jun expression (Fig. 
5A,B), suggesting that PKC activity was completely inhib- 
ited. Even if treatment with TGF-fl I induced a slight 
increase in c-fos mRNA level in TPA-pretreated cells, this 
increase (1.5-fold) was unrelated to those observed in 
control cells (l 1-fold). Under these conditions, we ob- 
served nonetheless that TGF-/31 still induced an increase 
in c-jun mRNA level (3-fold versus 4-fold in control). 
4. Discussion 
A major feature of the pleiotropic responses of cells to 
TGF-/31 is the induction of a set of genes that are involved 
in the regulation of cell growth and the interactions be- 
tween the cell and the extracellular matrix [1]. Our results 
indicate that TGF-fl 1 regulates autoinduction and inhibi- 
tion of cell proliferation in MCF-7 cells via distinct sig- 
nalling mechanisms. In addition, these results suggest that 
the growth inhibitory effect of TGF-fl I occurs in parallel 
with the induction of c-fos expression, essentially mediated 
by the PKC pathway. 
TGF-fl 1 inhibited proliferation of MCF-7 cells, but it 
failed to affect proliferation in the MCF-7(- )  cell line 
(Table 1). Acquisition of resistance of MCF-7( - ) cells to 
the antiproliferative effect of TGF-fl 1 is correlated with an 
undetectable level of type II TGF-fl receptor characterized 
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at the protein level by cross-linking studies in the present 
work and at the mRNA level by Northern blot analysis [9]. 
It has been reported that both type I and type II TGF-/3 
receptors are required for all the biological effects of 
TGF-/31 [11]. However, inactivation of type II TGF-/3 
receptors abolishes the growth inhibitory effect of TGF-/31 
without affecting its effects on the extracellular matrix 
[12]. Moreover, expression of recombinant type II TGF-/3 
receptors restores the inhibitory action of TGF-fll on 
growth of a resistant hepatoma cell line [31]. In this study, 
levels of mRNA of both PAI-1 and TGF-fl 1 were in- 
creased by TGF-fl 1 in both MCF-7 and MCF-7(- )  cells, 
indicating that in MCF-7(- )  cell line some responses to 
TGF-fl 1 were maintained. The various actions of TGF-/31 
are now thought o be mediated via different signal trans- 
duction pathways. For example, the growth inhibitory ef- 
fect of TGF-/31 is lost in cells transfected with T antigen 
of SV40, whereas timulation of extracellular matrix gene 
expression was not found to be affected by the presence of 
this antigen [32]. The distinction between the effects of 
TGF-/31 on growth and extracellular matrix gene expres- 
sion was also demonstrated by the fact that TGF-/31 
affected PAI-1 expression i  the S-phase as effectively as 
in the GI phase of the cell cycle, whereas the antiprolifera- 
tive response of TGF-fl 1 is restricted to the G1 phase [33]. 
The results of the present study show that growth in- 
hibitory effect of TGF-fl 1 and its ability to induce its own 
message are also dissociated. This fact suggest hat these 
two TGF-fl 1 effects are also transduced by independent 
mechanisms. Escape from the negative growth control by 
TGF-fl 1 has been postulated as a cause of the uncontrolled 
growth of cancer cells [34]. In transformed cells released 
from the regulatory effects of TGF-fl 1, the ability of these 
cells to synthesize and secrete levated levels of TGF-/31 
may be a critical factor enabling the tumor to escape 
immune surveillance [35]. It has been recently described 
that in tumor cells TGF-/3 1 has a role in the progression of 
mammary carcinoma by suppressing host immune surveil- 
lance [36]. Thus, in cells which have escaped from its 
antiproliferative action due to loss of type II TGF-fl recep- 
tor, the ability of TGF-/31 to activate its own secretion 
may indirectly support umor growth by a paracrine mech- 
anism targeted to fibroblasts, endothelial nd immune cells. 
It has been shown that the early genomic response to 
TGF-fl 1 includes an enhancement of c-jun and jun B 
expression in cell lines which are growth-inhibited or 
growth-stimulated by TGF-/31 [13,16]. The results of the 
present study, indicating that TGF-/31 induced a rise in 
mRNA levels of the jun gene family in MCF-7 cells 
irrespective of their sensitivity or resistance to its antipro- 
liferative effect, confirm these previous works [13,16]. 
However, the fact that c-jun increase induced by TGF-/3 1 
is higher in MCF-7 compared to MCF-7(- )  cells could 
suggest that c-jun induction play a role in TGF-/3 1 antipro- 
liferative ffect. Besides, treatment with TGF-/31 elicited a 
rapid and transient induction of c-fos mRNA in the MCF-7 
cells but not in the MCF-7( - ) cells. The induction of c-fos 
differed in both magnitude and time course as compared to 
those of c-jun, jun B and jun D. TGF-fll treatment 
resulted in a slight but prolonged induction of jun B and 
jun D mRNA. In contrast, the transient rise in c-fos 
mRNA may have been due to a c-fos-induced own-regu- 
lation of its expression [37]. The fact that induction of 
c-fos was only observed in cells which are growth-in- 
hibited by TGF-/31 raises the possibility that induction of 
c-fos mediates the antiproliferative effect of TGF-/31. In- 
duction of c-fos has also been described in human lung 
adenocarcinoma cells growth inhibited by TGF-/31 [ 13,15]. 
On the contrary, when observed in K562 human erythro- 
leukemia cells unresponsive to TGF-/31 antiproliferative 
effect, the enhanced expression of c-fos peaked at 5 h after 
TGF-/31 addition [13]. Therefore, it remains to be deter- 
mined whether the rapid induction of c-fos mediates the 
antiproliferative effect of TGF-fl 1 on MCF-7 cells. Au- 
toinduction of TGF-fl 1 is known to be mediated by a 
complex of jun and fos proteins referred to as the AP1 
complex [15]. Our results indicate that in the MCF-7( - )  
cell line there was no induction of c-fos gene expression, 
despite vidence for TGF-/31 autoinduction. This suggests 
that the basal level of c-fos expression is sufficient for 
TGF-/31 autoinduction. 
Various protein kinases such as PKC, protein kinase A 
or tyrosine kinase play a role in the activation of c-jun and 
c-fos (review in Ref. [38]). Increased expression of c-jun 
involves post-transcriptional modification of preexisting 
c-jun protein and an activation of its own transcription 
through AP1 binding sites. The c-fos promoter egion 
contains a serum responsive lement (SRE) which medi- 
ates transcription by PKC and a calcium/cAMP response 
element (CRE) which mediates transcriptional ctivation 
by Ca 2 ÷ and cAMP. Cross-talk between the PKC pathway 
and the TGF-/31 signalling system has been described in 
MCF-7 cells [22,39]. We have previously found that acti- 
vation of PKC by TPA in MCF-7 cells induced a more 
differentiated phenotype and an increase in TGF-/31 ex- 
pression [22,39]. The data presented here indicate that 
c-fos and c-jun expression could be induced in MCF-7 
cells in response to TPA and TGF-fl 1. However, when 
PKC was down-regulated by chronic TPA pretreatment, 
TPA was unable to further increase c-fos and c-jun mRNA 
levels, whereas TGF-/31 induced c-jun but not c-fos ex- 
pression. In addition, we have previously found that TGF- 
/31 is able to induce its own message in TPA resistant 
MCF-7 cells variant [22]. Whereas PAI-1 response to 
TGF-/31 is not affected by down-regulation f PKC [40], 
the TGF-/31 induction of carcinoembryonic antigen in 
human colon carcinoma cells is associated to PKC activa- 
tion[41]. This mechanism of TGF-/31 may implicate 
PKC-dependent and PKC-independent pathways. The 
functional link between PKC-dependent induction of c-fos 
and the growth-inhibitory effect of TGF-/31 remains to be 
demonstrated. 
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